Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
0.9700
Dollar change
-0.0200
Percentage change
-2.02
%
Index- P/E- EPS (ttm)-1.22 Insider Own56.65% Shs Outstand37.10M Perf Week-0.47%
Market Cap41.23M Forward P/E- EPS next Y-1.07 Insider Trans0.00% Shs Float18.42M Perf Month-2.95%
Income-52.47M PEG- EPS next Q-0.29 Inst Own23.87% Short Float0.44% Perf Quarter10.23%
Sales22.52M P/S1.83 EPS this Y7.38% Inst Trans-6.28% Short Ratio0.37 Perf Half Y-6.73%
Book/sh2.78 P/B0.35 EPS next Y5.60% ROA-31.41% Short Interest0.08M Perf Year-21.14%
Cash/sh2.17 P/C0.45 EPS next 5Y- ROE-37.19% 52W Range0.74 - 1.44 Perf YTD31.08%
Dividend Est.- P/FCF- EPS past 5Y-16.10% ROI-42.24% 52W High-32.63% Beta1.26
Dividend TTM- Quick Ratio5.29 Sales past 5Y11.76% Gross Margin-24.36% 52W Low31.08% ATR (14)0.05
Dividend Ex-Date- Current Ratio6.34 EPS Y/Y TTM14.84% Oper. Margin-251.18% RSI (14)48.01 Volatility3.59% 5.84%
Employees193 Debt/Eq0.06 Sales Y/Y TTM31.44% Profit Margin-232.99% Recom1.67 Target Price5.25
Option/ShortNo / Yes LT Debt/Eq0.05 EPS Q/Q32.92% Payout- Rel Volume0.59 Prev Close0.99
Sales Surprise3.04% EPS Surprise13.33% Sales Q/Q44.88% EarningsMar 01 BMO Avg Volume215.87K Price0.97
SMA20-1.67% SMA50-0.32% SMA200-2.80% Trades Volume127,349 Change-2.02%
Date Action Analyst Rating Change Price Target Change
Aug-16-22Downgrade JP Morgan Overweight → Neutral
Mar-19-24 04:30PM
Mar-12-24 04:50PM
Mar-06-24 06:40PM
Mar-04-24 08:57AM
Mar-01-24 11:08PM
06:30AM Loading…
06:30AM
Feb-27-24 04:30PM
Feb-20-24 04:36PM
Jan-10-24 07:22AM
07:20AM
Jan-04-24 07:00AM
Jan-03-24 07:15AM
Nov-07-23 04:15PM
Nov-05-23 09:34AM
Nov-03-23 08:45AM
08:40AM Loading…
08:40AM
07:00AM
Oct-19-23 04:15PM
Sep-29-23 09:25AM
Sep-19-23 05:15PM
Sep-08-23 09:10PM
Sep-06-23 04:15PM
Aug-04-23 10:01PM
08:15AM
07:00AM
Jul-20-23 08:00AM
Jul-18-23 05:20PM
Jul-05-23 12:00PM
May-09-23 05:45PM
May-05-23 11:50PM
08:25AM Loading…
08:25AM
07:00AM
May-04-23 04:30PM
Apr-13-23 04:05PM
Mar-06-23 10:00AM
Mar-04-23 12:02AM
Mar-03-23 08:15AM
07:00AM
Feb-28-23 04:52PM
Feb-16-23 04:05PM
05:50AM
Jan-11-23 09:00AM
Jan-05-23 08:00AM
Dec-07-22 04:30PM
Dec-01-22 08:00AM
Nov-10-22 08:25AM
07:00AM
Nov-02-22 08:00AM
Oct-10-22 08:30AM
Oct-04-22 08:30AM
Sep-12-22 09:00AM
Sep-02-22 09:10PM
Aug-12-22 07:00PM
11:10AM
08:25AM
07:00AM
07:00AM
Aug-09-22 08:00AM
Jul-08-22 04:19PM
Jun-30-22 02:33PM
08:30AM
Jun-20-22 12:05PM
May-11-22 07:00AM
May-10-22 06:00AM
May-06-22 11:55AM
Apr-26-22 04:10PM
Apr-04-22 10:15AM
Mar-17-22 10:00AM
Mar-08-22 04:16AM
Mar-04-22 12:30PM
06:00AM
Feb-23-22 04:45PM
Feb-17-22 04:10PM
Jan-20-22 04:30PM
Jan-09-22 06:00PM
Dec-23-21 05:16PM
Nov-13-21 02:30AM
Nov-11-21 06:15PM
Oct-29-21 07:30AM
Oct-19-21 07:30AM
Oct-15-21 10:55AM
Oct-05-21 05:15PM
Sep-30-21 12:20PM
Sep-09-21 07:30AM
Aug-31-21 08:00AM
Aug-26-21 04:05PM
Aug-12-21 04:30PM
Aug-04-21 04:28PM
Aug-03-21 04:30PM
Jul-20-21 07:00AM
Jul-14-21 09:30PM
Rapid Micro Biosystems, Inc. is a life sciences technology company. It provides automated solutions to facilitate the efficient manufacturing and safe release of healthcare products such as biologics, vaccines, cell & gene therapies, and sterile injectable. The company was founded by Donald Straus on December 29, 2006 and is headquartered in Lowell, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WIRTJES SEAN MCHIEF FINANCIAL OFFICERSep 06 '23Buy0.9910,0009,894285,651Sep 08 07:36 AM
Spignesi Robert G. Jr.PRESIDENT AND CEOAug 15 '23Buy0.9720,00019,488375,512Aug 16 07:13 PM
Spignesi Robert G. Jr.PRESIDENT AND CEOAug 08 '23Buy0.9234,00031,447355,512Aug 10 04:15 PM
Spignesi Robert G. Jr.PRESIDENT AND CEOMay 17 '23Buy0.9120,00018,204321,512May 18 04:12 PM